Skip to main content
KPET logo

KPET · KPET Ultra Paceline Corp

Track KPET — free
$10.05 At close · Nov 13
Market Cap
$291.30M
Shares
28.98M
Volume · Nov 13 10.21K Avg daily vol (3M) 37.9K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$10.05 Open$10.05 Day$10.05–10.07 Available close range$9.95–10.12 Avg vol 30d37K Short int56 · 0.0% of shares · 1.0d Short vol25% DataMay 2026–Nov 2026 Filing10-Q · Nov 13

The closing range uses available history since May 26, 2026; less than a full year is stored.

Latest documents

2026
Nov 13
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Disclosure controls ineffective over related-party note accounting

KPET Ultra Paceline Corporation reported net income of $3,534,303 for the nine months ended September 30, 2026, while disclosure controls were ineffective due to a material weakness in accounting for a related party promissory note.

Read from the MD&A section
3 source passages
References to “KPET”, “our,” “us,” “we” or the “Company” in this report (the “Quarterly Report”) refer to KPET Ultra Paceline Corporation. For the nine months ended September 30, 2026, we had net income of $3,534,303, which consisted of change in fair value of over-allotment option liability of $57,000 and interest earned on investments held in the Trust Account of $4,075,777, offset by formation, general and administrative costs of $598,474. Based on the foregoing, our Certifying Officers concluded that our disclosure controls and procedures were not effective as of September 30, 2026, due to a material weakness in our internal controls over financial reporting related to accounting for a related party promissory note as described in Note 2 to the accompanying unaudited condensed financial statements. Open the document at this passage
May 21
Current report 8-K
Other events AI summary on its way
Apr 22
Current report 8-K Events of Apr 20
Other events AI summary on its way
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$1.22M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
0.0%
Latest settlement · 1.0 days to cover
View all 125 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Buy
SellHoldBuy
Technical Buy Momentum Limited Sentiment Bullish Fundamentals Limited Quant / Vol Very Low
Market backdrop VIX 24.6 · elevated Equity put/call 0.72
Technical
price trend
Buy
50 / 200-day cross No cross
RSI (14) 63
neutral
MACD trend Positive
52-week position 59%
mid-range
Momentum
relative strength
Limited
Not enough data for a confident read.
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Accumulating
+8% holders QoQ · +5 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.00% of shares out · ▼ -16.4% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
40 holders — 13F breadth
Squeeze score 28
low risk · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very Low
Volatility 6%
annualized · 1-yr
Max drawdown −2%
past year
ATR 0.2%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy
0 · 3 · 1
50 / 200-day cross
No cross Neutral
RSI (14)
63 Neutral
MACD trend
Positive Bullish
52-week position
59% Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Accumulating
+8% holders QoQ · +5 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.00% of shares out · ▼ -16.4% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
40 holders — 13F breadth
Price context
position in its available closing range
Range low $10 Now $10 · 59% Range high $10

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.

Versus peers

Shell Companies — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
KPET
KPET Ultra Paceline Corp
this stock
$291.30M — — — 0.0%
VYLR
Vylor Inc.
$46.59B — — — 2.1%
CLUS
Cluster Group Holdings Ltd Co
$8.00B — — — —
DMII
Drugs Made In America Acquisition II Corp.
$651.65M +3.3% — — 0.2%
EVAC
EQV Ventures Acquisition Corp. II
$606.10M +3.4% — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
40
% held
63.6%
Net QoQ
+776.4K sh
Top holder
ADAGE CAPITAL PARTNERS GP…
Held Float
View
Held by Funds
Fund positions
2
View
Short & Settlement
Short Interest Falling
Shares short
56
Days to cover
1.0d
Change
-11 sh
View
Short Volume
Short vol %
25%
As of
Nov 18, 2026
Short Total
View
Fails to Deliver
FTD shares
424
Value
$4.2K
As of
Jul 30, 2026
View
Off-Exchange
Off-exchange %
100.0%
Week of
Oct 12, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
10-Q
Filed
Nov 13, 2026
This year
9

KPET Ultra Paceline Corporation reported net income of $3,534,303 for the nine months ended September 30, 2026, while disclosure controls were ineffective due to a material weakness in accounting for a related party promissory note.

View
Earnings & Events
Investor Relations
Latest news
KPET Ultra Paceline Corporation A…
Published
Mar 30, 2026
View

Performance

5D 20D 120D MTD YTD
KPET +0.6% +0.7% — +0.5% —
SPY +2.6% -1.2% +0.5% -0.2% +10.6%
vs SPY -2.0% +1.9% — +0.7% —
Key facts CIK 2095297 CUSIP G53157106 13F (30d) 40 filings 40 filers Visit website Investor relations